clinical trials

This year a clinical trial will test a drug combination designed to bring lasting relief for people with panic disorder – a condition that can upend daily life and be notoriously difficult to treat. No new medications have been approved since 2003.

People with fibromyalgia will soon have access to a new drug that treats the chronic pain condition's most elusive trigger: Poor sleep. Tonmya, a non-opioid under-the-tongue tablet, is the first FDA-approved drug for fibromyalgia in more than 15 years.

A novel drug, evenamide, quieted overactive brain circuits in an animal model of schizophrenia, improving memory, social interaction, and dopamine balance, offering hope for tackling symptoms that current antipsychotics can’t touch.

We're closing in on an oral male pill that doesn't change hormones or libido, is fully reversible and has no side effects. YCT-529, a new kind of contraceptive mechanism, has also sparked debate about disparities in men's and women's health research.

Scientists have developed a non-opioid oral painkiller known as ADRIANA, the world's first α2B-adrenoceptor antagonist – which hasn't been targeted for analgesics before. It's provided powerful pain relief without sedation or risk of addiction.

It looks like we'll see oral GLP-1 drugs on the market by 2026, with Eli Lilly reporting impressive results from a large, robust 72-week trial that saw obese patients lose an average of 27.3 lb, or 12.4% of their body weight, with a once-daily pill.

What if you could inject a drug into a "problem area" – like the abdomen – and have it safely and rapidly kill off fat cells? We could be within 12 months of this reality, as the world's first safe, targeted fat-loss jab enters Phase 3 trials.

From St John’s wort to vitamin D, the range of over-the-counter supplements for mental health wellbeing continues to grow. Now, scientists have looked at 64 products reviewed in hundreds of studies to shed light on how useful they are for depression.

A safe and affordable treatment to effectively combat the progress of Parkinson's dementia has emerged – in the form of a commonly available cough syrup that's already being studied for its brain-protecting power in other degenerative diseases.

A clinical trial has shown that Ozempic improves blood glucose levels and weight loss in overweight type 1 diabetics who use an automated insulin delivery system. It’s hoped this will lead to the approval of Ozempic for this patient population.

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch relief and clear skin for many patients in a clinical trial, without the common side effects associated with other therapies.

Over the weekend, Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing what appears to be a strategic "something for everyone" plan of attack from the pharmaceutical giant.